Your browser doesn't support javascript.
loading
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.
Tankel, James; Spicer, Jonathan; Chu, Quincy; Fiset, Pierre Olivier; Kidane, Biniam; Leighl, Natasha B; Joubert, Philippe; Maziak, Donna; Palma, David; McGuire, Anna; Melosky, Barbara; Snow, Stephanie; Bahig, Houda; Blais, Normand.
Afiliação
  • Tankel J; Department of Thoracic Surgery, McGill University Health Center, Montreal, QC H3G 1A4, Canada.
  • Spicer J; Department of Thoracic Surgery, McGill University Health Center, Montreal, QC H3G 1A4, Canada.
  • Chu Q; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
  • Fiset PO; Department of Pathology, McGill University Health Center, Montreal, QC H3G 1A4, Canada.
  • Kidane B; Section of Thoracic Surgery, University of Manitoba & Cancer Care Manitoba, Winnipeg, MB R3A 1R9, Canada.
  • Leighl NB; Division of Medical Oncology, Princess Margaret Cancer Center, Toronto, ON M5G 2C4, Canada.
  • Joubert P; Department of Pathology, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université, Laval, QC G1V 4G5, Canada.
  • Maziak D; Department of Thoracic Surgery, Ottawa Hospital, Ottawa, ON K1Y 4E9, Canada.
  • Palma D; Department of Radiation Oncology, London Health Services Center, London, ON N6A 5A5, Canada.
  • McGuire A; Department of Thoracic Surgery, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada.
  • Melosky B; Department of Medical Oncology, BCCA, Vancouver, BC V5Z 4E6, Canada.
  • Snow S; Department of Medical Oncology, Queen Elizabeth II Health Sciences Center, Halifax, NS B3H 3A7, Canada.
  • Bahig H; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 3E4, Canada.
  • Blais N; Department of Medical Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 3E4, Canada.
Curr Oncol ; 30(12): 10363-10384, 2023 12 06.
Article em En | MEDLINE | ID: mdl-38132389
ABSTRACT
The treatment paradigm for patients with stage II/III non-small-cell lung cancer (NSCLC) is rapidly evolving. We performed a modified Delphi process culminating at the Early-stage Lung cancer International eXpert Retreat (ELIXR23) meeting held in Montreal, Canada, in June 2023. Participants included medical and radiation oncologists, thoracic surgeons and pathologists from across Quebec. Statements relating to diagnosis and treatment paradigms in the preoperative, operative and postoperative time periods were generated and modified until all held a high level of consensus. These statements are aimed to help guide clinicians involved in the treatment of patients with stage II/III NSCLC.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article